Literature DB >> 1572421

Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study.

A E Czeizel1, M Bod, P Halász.   

Abstract

The Hungarian Case-Control Surveillance of Congenital Anomalies, from 1980-1987, involved 10,698 malformed cases and 21,546 non-malformed controls. Ninety-five pregnant women were treated by 144 anticonvulsants excluding diazepam and barbiturates. The rate of anticonvulsant use was 2.9 times higher in pregnant women having malformed offspring than in control mothers and this difference was greater in polytherapy than in monotherapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572421     DOI: 10.1007/bf03334986

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  14 in total

Review 1.  Drug-induced congenital defects: strategies to reduce the incidence.

Authors:  M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy.

Authors:  A Ornoy; E Cohen
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

Review 3.  Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing?

Authors:  Carmela Palmieri; Raffaele Canger
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 4.  Antiepileptic drugs and pregnancy outcomes.

Authors:  Bogdan J Wlodarczyk; Ana M Palacios; Timothy M George; Richard H Finnell
Journal:  Am J Med Genet A       Date:  2012-06-18       Impact factor: 2.802

Review 5.  Teratogenic effects of antiepileptic drugs.

Authors:  Denise S Hill; Bogdan J Wlodarczyk; Ana M Palacios; Richard H Finnell
Journal:  Expert Rev Neurother       Date:  2010-06       Impact factor: 4.618

6.  Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsants.

Authors:  Sonia Hernández-Díaz; Michael Levin
Journal:  Reprod Toxicol       Date:  2014-05-06       Impact factor: 3.143

Review 7.  Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts.

Authors:  Kimford Meador; Matthew W Reynolds; Sheila Crean; Kyle Fahrbach; Corey Probst
Journal:  Epilepsy Res       Date:  2008-06-18       Impact factor: 3.045

Review 8.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.

Authors:  Kevin G Bath; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-08       Impact factor: 2.937

10.  Risk and benefit of drug use during pregnancy.

Authors:  Ferenc Bánhidy; R Brian Lowry; Andrew E Czeizel
Journal:  Int J Med Sci       Date:  2005-07-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.